Value of Fecal Calprotectin Measurement During the Initial Period of Therapeutic Anti-Tubercular Trial
Hyeong Ho Jo, Eun Young Kim, Jin Tae Jung, Joong Goo Kwon, Eun Soo Kim, Hyun Seok Lee, Yoo Jin Lee, Kyeong Ok Kim, Byung Ik Jang,
Clin Endosc 2022;55(2):256-262.   Published online 2021 Nov 5     DOI:
Citations to this article as recorded by Crossref logo
Evidence-based approach to diagnosis and management of abdominal tuberculosis
Daya Krishna Jha, Mythili Menon Pathiyil, Vishal Sharma
Indian Journal of Gastroenterology.2023; 42(1): 17.     CrossRef
Primary Gastric Tuberculosis in an Immunocompetent Patient: The Truth Lying beneath the Surface
Fábio Pereira Correia, Luísa Martins Figueiredo, Luís Carvalho Lourenço, Sofia Santos, Rita Theias Manso, David Horta
GE - Portuguese Journal of Gastroenterology.2023; : 1.     CrossRef
Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial
Satimai Aniwan
Clinical Endoscopy.2022; 55(2): 210.     CrossRef